Moreover, previous studies have shown the prevalence of PD-L1-expressing CD8+ cells in the GATA3/CR5/6-negative immune microenvironment along with the moderate to high expression of the biomarker by tumor cells [29]. This evidence concerns the gene GATA3 and neoplasm.